PUBLICATION

Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development

Authors
Laue, K., Jänicke, M., Plaster, N., Sonntag, C., and Hammerschmidt, M.
ID
ZDB-PUB-081022-35
Date
2008
Source
Development (Cambridge, England)   135(22): 3775-3787 (Journal)
Registered Authors
Hammerschmidt, Matthias, Laue, Kathrin, Plaster, Nikki, Sonntag, Carmen
Keywords
Cyp26b1, Retinoic acid, Bmp2, Cartilage, Bone, Chondrocyte, Osteoblast, Osteopontin, Osterix, Craniofacial development, Vertebra, Zebrafish
MeSH Terms
  • Branchial Region/embryology
  • Branchial Region/enzymology
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism
  • Osteoblasts/enzymology
  • Mice
  • Osteopontin/metabolism
  • Gene Expression Regulation, Enzymologic
  • Cytochrome P-450 Enzyme System/genetics
  • Cytochrome P-450 Enzyme System/metabolism*
  • Body Patterning*
  • Tretinoin/metabolism*
  • Gene Expression Regulation, Developmental*
  • Mutation/genetics
  • Bone Morphogenetic Protein 2/genetics
  • Bone Morphogenetic Protein 2/metabolism
  • Base Sequence
  • Zebrafish/embryology*
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Animals
  • Phenotype
  • Osteogenesis*
  • Animals, Genetically Modified
(all 24)
PubMed
18927157 Full text @ Development
Abstract
Skeletal syndromes are among the most common birth defects. Vertebrate skeletogenesis involves two major cell types: cartilage-forming chondrocytes and bone-forming osteoblasts. In vitro, both are under the control of retinoic acid (RA), but its exact in vivo effects remained elusive. Here, based on the positional cloning of the dolphin mutation, we have studied the role of the RA-oxidizing enzyme Cyp26b1 during cartilage and bone development in zebrafish. cyp26b1 is expressed in condensing chondrocytes as well as in osteoblasts and their precursors. cyp26b1 mutants and RA-treated wild-type fish display a reduction in midline cartilage and the hyperossification of facial and axial bones, leading to fusions of vertebral primordia, a defect not previously described in the context of RA signaling. Fusions of cervical vertebrae were also obtained by treating mouse fetuses with the specific Cyp26 inhibitor R115866. Together with data on the expression of osteoblast markers, our results indicate that temporal and spatial restriction of RA signaling by Cyp26 enzymes is required to attenuate osteoblast maturation and/or activity in vivo. cyp26b1 mutants may serve as a model to study the etiology of human vertebral disorders such as Klippel-Feil anomaly.
Genes / Markers
Figures
Figure Gallery (13 images) / 2
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
fr13TgTransgenic Insertion
    sa2
      Point Mutation
      ti230g
        Unknown
        y1TgTransgenic Insertion
          1 - 4 of 4
          Show
          Human Disease / Model
          No data available
          Sequence Targeting Reagents
          Target Reagent Reagent Type
          aldh1a2MO1-aldh1a2MRPHLNO
          aldh1a2MO2-aldh1a2MRPHLNO
          cyp26b1MO5-cyp26b1MRPHLNO
          1 - 3 of 3
          Show
          Fish
          Antibodies
          Orthology
          No data available
          Engineered Foreign Genes
          Marker Marker Type Name
          EGFPEFGEGFP
          1 - 1 of 1
          Show
          Mapping
          Entity Type Entity Symbol Location
          Featureti230gChr: 7 Details
          GENEcyp26b1Chr: 7 Details
          1 - 2 of 2
          Show